Illuminated neural pathways represent neuro plasticity from mystical psychedelic experiences

Mystical and Insightful Psychedelic Experience May Improve Mental Health

Summary: Recent studies have explored the use of psychedelics for the treatment of a range of mental health disorders. A new study reveals more insightful and mystical “trips” while exposed to psychedelics may be linked to an enduring reduction of symptoms for those with anxiety and depression. Source: Ohio State University A more mystical and […]

Mystical and Insightful Psychedelic Experience May Improve Mental Health Read More »

Psychedelic mushrooms grown wild

Australia becomes first country to legalize therapeutic use of MDMA and psilocybin

After decades of criminalization, Australia’s government said Friday that it will legalize the prescription of MDMA and psilocybin for the treatment of two medical conditions, a historic move hailed by researchers who have studied the therapeutic possibilities of the drugs. Australia’s Therapeutic Goods Administration (TGA) said in a statement that starting July 1, psychiatrists may

Australia becomes first country to legalize therapeutic use of MDMA and psilocybin Read More »

Downtown Denver skyline

Be Part of the Breakthrough: Psychedelic Science 2023

Join MAPS and the global psychedelic community for the fourth Psychedelic Science conference. Discover the future of Psychedelic Science through informative talks, valuable workshops, exciting events and marketplace opportunities. Gain insights and findings from a large, diverse roster of guests and speakers across Colorado Convention Center’s seven stages.300+ Speakers Learn about the latest research and

Be Part of the Breakthrough: Psychedelic Science 2023 Read More »

A small mushroom perched on a legislator's desk in the Missouri capitol

Missouri Representative Files Bill Legalizing Psilocybin Access

Last week, Missouri State Representative Tony Lovasco filed House Bill 869 to create legal access to psilocybin therapy in Missouri. A press release from Rep. Lovasco included statements of support from clinical researchers, veterans advocates, and law enforcement: Rep. Lovasco’s proposal comes as Compass Pathways initiates a Stage 3 clinical trial with 233 patients. In

Missouri Representative Files Bill Legalizing Psilocybin Access Read More »

Jordan Sloshower MD

Blinding in Clinical Trials Investigating Psychedelic Medicine Remains Difficult

Pharmacy Times interviewed Jordan Sloshower, MD, MSc, a clinical instructor of psychiatry at the Yale Department of Psychiatry, a member of Chacruna’s Council for the Protection of Sacred Plants, a clinical investigator in MAPS’ Expanded Access Program, a trainer with Usona Institute, co-director of West Rock Wellness, PLLC, and a member of the Board of

Blinding in Clinical Trials Investigating Psychedelic Medicine Remains Difficult Read More »

Scott Barry Kaufman standing in front of a stone wall

The Scientific Psychedelics Revolution and Embracing Mortality

Roland Griffiths & David Yaden || An Ode to Joy Scott Barry Kaufman is a cognitive scientist and humanistic psychologist exploring the mind, creativity, and the depths of human potential. He is a professor at Columbia University and founder and director of the Center for Human Potential. Dr. Kaufman has taught at Columbia University, Yale,

The Scientific Psychedelics Revolution and Embracing Mortality Read More »

Scroll to Top